CY2008018I2 - Παραγωγα 6-μepκαπτο-κυκλοδεξτρινης: παραγοντες αναστροφης του νευρoμυϊκου αποκλεισμου που προκαλειται απο φαρμακευτικες ουσιες - Google Patents

Παραγωγα 6-μepκαπτο-κυκλοδεξτρινης: παραγοντες αναστροφης του νευρoμυϊκου αποκλεισμου που προκαλειται απο φαρμακευτικες ουσιες

Info

Publication number
CY2008018I2
CY2008018I2 CY200800018C CY2008018C CY2008018I2 CY 2008018 I2 CY2008018 I2 CY 2008018I2 CY 200800018 C CY200800018 C CY 200800018C CY 2008018 C CY2008018 C CY 2008018C CY 2008018 I2 CY2008018 I2 CY 2008018I2
Authority
CY
Cyprus
Prior art keywords
neuromusical
mecapto
blockage
induced
agents
Prior art date
Application number
CY200800018C
Other languages
Greek (el)
English (en)
Other versions
CY2008018I1 (el
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8241767&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2008018(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of CY2008018I1 publication Critical patent/CY2008018I1/el
Publication of CY2008018I2 publication Critical patent/CY2008018I2/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CY200800018C 1999-11-29 2008-11-25 Παραγωγα 6-μepκαπτο-κυκλοδεξτρινης: παραγοντες αναστροφης του νευρoμυϊκου αποκλεισμου που προκαλειται απο φαρμακευτικες ουσιες CY2008018I2 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99309558 1999-11-29
PCT/EP2000/011789 WO2001040316A1 (en) 1999-11-29 2000-11-23 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
EP00993261A EP1259550B1 (en) 1999-11-29 2000-11-23 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block

Publications (2)

Publication Number Publication Date
CY2008018I1 CY2008018I1 (el) 2009-11-04
CY2008018I2 true CY2008018I2 (el) 2009-11-04

Family

ID=8241767

Family Applications (1)

Application Number Title Priority Date Filing Date
CY200800018C CY2008018I2 (el) 1999-11-29 2008-11-25 Παραγωγα 6-μepκαπτο-κυκλοδεξτρινης: παραγοντες αναστροφης του νευρoμυϊκου αποκλεισμου που προκαλειται απο φαρμακευτικες ουσιες

Country Status (33)

Country Link
US (3) US6670340B1 (en:Method)
EP (1) EP1259550B1 (en:Method)
JP (2) JP3880041B2 (en:Method)
KR (1) KR100716524B1 (en:Method)
CN (1) CN1188428C (en:Method)
AR (1) AR026605A1 (en:Method)
AT (1) ATE288450T1 (en:Method)
AU (1) AU776536B2 (en:Method)
BE (1) BE2008C047I2 (en:Method)
BR (1) BRPI0015947B8 (en:Method)
CA (1) CA2390463C (en:Method)
CO (1) CO5251450A1 (en:Method)
CY (1) CY2008018I2 (en:Method)
CZ (1) CZ298206B6 (en:Method)
DE (2) DE60017947T2 (en:Method)
DK (1) DK1259550T3 (en:Method)
ES (1) ES2237496T3 (en:Method)
FR (1) FR08C0052I2 (en:Method)
HU (1) HU227451B1 (en:Method)
IL (1) IL149423A0 (en:Method)
LU (1) LU91501I2 (en:Method)
MX (1) MXPA02004940A (en:Method)
NL (1) NL300356I2 (en:Method)
NO (2) NO328790B1 (en:Method)
NZ (1) NZ518752A (en:Method)
PE (1) PE20010902A1 (en:Method)
PL (1) PL203012B1 (en:Method)
PT (1) PT1259550E (en:Method)
RU (1) RU2260013C2 (en:Method)
SK (1) SK286282B6 (en:Method)
TW (1) TWI242015B (en:Method)
WO (1) WO2001040316A1 (en:Method)
ZA (1) ZA200203538B (en:Method)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6744471B1 (en) * 1997-12-05 2004-06-01 Olympus Optical Co., Ltd Electronic camera that synthesizes two images taken under different exposures
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
ATE337790T1 (de) * 2000-11-02 2006-09-15 Akzo Nobel Nv Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
CA2543443A1 (en) 2003-10-31 2005-05-12 The University Of Kansas Sulfoalkyl ether-alkyl ether cyclodextrin derivatives
US7851457B2 (en) 2004-01-29 2010-12-14 Innovative Biologics, Inc. β-Cyclodextrin derivatives
BRPI0510119A (pt) 2004-04-23 2007-09-25 Cydex Inc formulação para dpi contendo sulfoaquil éter de ciclodextrina
JP2008528761A (ja) 2005-01-28 2008-07-31 ピナクル ファーマシューティカルズ，インク． 抗菌剤としてのβ−シクロデキストリン誘導体
PT2952197T (pt) 2005-10-26 2017-07-28 Cydex Pharmaceuticals Inc Composições de éter sulfoalquílico de ciclodextrina e métodos para a sua preparação
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20090069412A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched sugammadex
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
US7938283B2 (en) * 2008-06-20 2011-05-10 Grainpro, Inc. System and method for hermetic storage of agricultural commodities during shipping
WO2010053487A1 (en) 2008-11-07 2010-05-14 Cydex Pharmaceuticals, Inc. Composition containing sulfoalkyl ether cyclodextrin and latanoprost
CN101591402B (zh) * 2009-05-05 2011-11-30 杭州奥默医药技术有限公司 6-脱氧砜类环糊精衍生物及其制备方法
US8492538B1 (en) 2009-06-04 2013-07-23 Jose R. Matos Cyclodextrin derivative salts
DE102010012281A1 (de) 2010-03-22 2011-09-22 Fresenius Medical Care Deutschland Gmbh Pharmazeutische Zusammensetzungen enthaltend substituiertes 6-Deoxy-6-sulfanylcyclodextrin
CN101864003B (zh) * 2010-06-11 2012-05-02 漆又毛 一种6-脱氧硫醚氨基酸环糊精衍生物的合成方法
EP2609120B1 (en) * 2010-08-25 2015-07-29 Davuluri, Ramamohan Rao Improved process for preparation of sugammadex
CN102060941B (zh) 2010-11-26 2012-12-26 漆又毛 6-脱氧α-氨基酸衍生物环糊精及制备和应用
WO2013123254A1 (en) 2012-02-15 2013-08-22 Cydex Pharmaceuticals, Inc. Manufacturing process for cyclodextrin derivatives
CA2865950C (en) 2012-02-28 2016-12-20 Cydex Pharmaceuticals, Inc. Alkylated cyclodextrin compositions and processes for preparing and using the same
JP5892847B2 (ja) * 2012-04-27 2016-03-23 Ｄｏｗａホールディングス株式会社 シクロデキストリンとシリカ含有物質との複合材料、及びその製造方法、並びにガス吸着剤
GB201211153D0 (en) * 2012-06-22 2012-08-08 Farmhispania Pharmaceutical compositions
US10040872B2 (en) 2012-10-22 2018-08-07 Cydex Pharmaceuticals, Inc. Alkylated cyclodextrin compositions and processes for preparing and using the same
WO2014125501A1 (en) 2013-02-14 2014-08-21 Neuland Laboratories Limited An improved process for preparation of sugammadex sodium
WO2015179963A1 (en) 2014-05-29 2015-12-03 Uti Limited Partnership Cyclodextrin-based polyanionic and non-ionic dendrimers
RU2705996C2 (ru) 2014-06-26 2019-11-13 Маруиси Фармасьютикал Ко., Лтд. Препарат рокурония с улучшенной стабильностью
CN105348412B (zh) * 2014-08-22 2018-06-05 江苏恩华药业股份有限公司 一种舒更葡糖钠的纯化方法
EP3183295B1 (en) 2014-08-22 2023-08-02 CyDex Pharmaceuticals, Inc. Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
US10702568B2 (en) 2015-03-19 2020-07-07 Cydex Pharmaceuticals, Inc. Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
CN104844732B (zh) * 2015-03-27 2017-05-03 山东滨州智源生物科技有限公司 一种舒更葡糖钠的制备方法
EP3280740A4 (en) * 2015-04-08 2019-03-27 Ling, Chang-Chun PHARMACEUTICAL COMPOSITIONS OF POLYANIONIC AND NONIONIC CYCLODEXTRIN BASED DENDRIMERS AND USES THEREOF
US10494450B2 (en) * 2015-05-29 2019-12-03 Lakshmi Prasad ALAPARTHI Processes for preparation of Sugammadex and intermediates thereof
CN104922693A (zh) * 2015-06-19 2015-09-23 南开大学 一种阴离子型环糊精与抗癌药物包合物及制备方法
JP2018530653A (ja) * 2015-10-07 2018-10-18 ユーティアイ リミテッド パートナーシップＵｔｉ Ｌｉｍｉｔｅｄ Ｐａｒｔｎｅｒｓｈｉｐ 多官能性ポリアニオン性シクロデキストリンデンドリマー
AU2016359420B2 (en) 2015-11-25 2020-10-01 Fresenius Kabi Ipsum S.R.L. An improved process for the preparation of sugammadex and its intermediates
EP3741801A1 (en) 2015-11-25 2020-11-25 Fresenius Kabi iPSUM S.r.l. Crystalline forms of per-chloro-gamma-cyclodextrines
JP6829304B2 (ja) * 2016-03-22 2021-02-10 フレゼニウス カビ イプスム エス．アール．エルＦｒｅｓｅｎｉｕｓ Ｋａｂｉ Ｉｐｓｕｍ Ｓ．Ｒ．Ｌ． スガマデクスの調製のための改善されたプロセス
WO2017188820A1 (en) * 2016-04-29 2017-11-02 Stichting Sanquin Bloedvoorziening Cyclodextrins as procoagulants
ES2915423T3 (es) 2016-06-23 2022-06-22 Synthon Bv Proceso de preparación de sugammadex
WO2017084401A1 (zh) 2016-06-29 2017-05-26 北京睿创康泰医药研究院有限公司 舒更葡糖钠的制备及纯化方法
US10526422B2 (en) 2016-06-29 2020-01-07 Beijing Creatron Institute Of Pharmaceutical Research Co., Ltd. Process for preparation and purification of Sugammades sodium
CN107778383B (zh) * 2016-08-24 2020-03-10 王炳永 一种舒更葡糖钠的精制方法
US10385142B2 (en) 2017-01-23 2019-08-20 Scinopharm Taiwan, Ltd. Method for preparing sugammadex sodium
CA3062308A1 (en) 2017-05-03 2018-11-08 Cydex Pharmaceuticals, Inc. Composition containing cyclodextrin and busulfan
CN109021148B (zh) * 2017-06-08 2020-11-10 天津科伦药物研究有限公司 一种制备舒更葡糖钠的方法
US10442871B2 (en) * 2017-06-22 2019-10-15 Lawrence Livermore National Security, Llc Modified cyclodextrins for the selective sequestration of fentanyl related compounds and uses thereof
ES2761899T3 (es) 2017-06-30 2020-05-21 Synthon Bv Proceso para preparar Sugammadex
US10233263B1 (en) * 2017-08-23 2019-03-19 Formosa Laboratories, Inc. Method for preparation of sugammadex sodium
TWI703163B (zh) * 2017-08-23 2020-09-01 台耀化學股份有限公司 舒更葡糖鈉之製備方法及其晶型
US11104746B2 (en) 2017-11-27 2021-08-31 Medichem, S.A. Process for the synthesis of a cyclodextrin derivative
CN107892727B (zh) * 2017-11-27 2019-12-24 合肥博思科创医药科技有限公司 一种舒更葡糖钠的纯化方法
WO2019193198A1 (en) 2018-04-06 2019-10-10 Synthon B.V. Purification of sugammadex
KR102054228B1 (ko) * 2018-05-28 2019-12-10 연성정밀화학(주) 슈가마덱스 나트륨염의 제조방법
US11634511B2 (en) 2018-06-07 2023-04-25 Merck Sharp & Dohme Llc Processes for the preparation of sugammadex
CN110615860A (zh) * 2018-06-20 2019-12-27 江苏恒瑞医药股份有限公司 一种舒更葡糖钠的纯化方法
ES3034771T3 (en) 2018-08-02 2025-08-22 Tapi Croatia Ind Ltd Solid state forms of sugammadex sodium
US11845811B2 (en) 2018-09-20 2023-12-19 Natco Pharma Limited Process for the preparation of Sugammadex sodium and its novel polymorphic form
JP2022501489A (ja) * 2018-09-27 2022-01-06 ヴェルテンシュタイン・バイオファーマ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング スガマデクスの新規結晶型
JP6950966B2 (ja) * 2018-11-01 2021-10-13 丸石製薬株式会社 スガマデクス又はその薬理学的に許容される塩含有液剤及びその製造方法
CN109438591B (zh) * 2018-12-29 2021-02-09 博瑞生物医药（苏州）股份有限公司 舒更葡糖钠的制备工艺
CN109824800A (zh) * 2018-12-29 2019-05-31 鼎元(天津)生物医药科技有限公司 一种选择性肌松拮抗药舒更葡萄糖钠的制备方法
US20220169753A1 (en) 2019-03-29 2022-06-02 Hospira, Inc. An improved process for preparation of sugammadex acid and sugammadex sodium
CN111978435B (zh) 2019-05-22 2021-05-25 合肥博思科创医药科技有限公司 一种高纯度舒更葡糖钠的制备方法
US11324692B2 (en) 2019-07-03 2022-05-10 Galenicum Health S.L.U. Method to prepare pharmaceutical compositions of suggamadex
EP4023292A4 (en) 2019-08-30 2023-09-06 TERUMO Kabushiki Kaisha INJECTION FORMULATION
RU2724900C1 (ru) * 2019-10-24 2020-06-26 Маруиси Фармасьютикал Ко., Лтд. Препарат рокурония с улучшенной стабильностью
CN111019016B (zh) * 2019-12-27 2022-02-18 武汉嘉诺康医药技术有限公司 一种舒更葡糖钠杂质的合成方法
US20230167203A1 (en) 2020-02-28 2023-06-01 Medichem, S.A. Method for drying sugammadex
CN111714459B (zh) * 2020-06-18 2022-06-14 广州瑞尔医药科技有限公司 一种注射用舒更葡糖钠粉针剂及其制备方法
US11097023B1 (en) 2020-07-02 2021-08-24 Par Pharmaceutical, Inc. Pre-filled syringe containing sugammadex
EP3932391A1 (en) 2020-07-03 2022-01-05 Galenicum Health S.L.U. Method to prepare pharmaceutical compositions
US11446325B2 (en) * 2020-09-30 2022-09-20 Cyclolab Cyclodextrin Research And Development Laboratory Ltd. Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases
US11945788B2 (en) 2021-06-07 2024-04-02 Nuray Chemicals Private Limited Process for preparing pitolisant hydrochloride and solid-state forms thereof
CN113637097A (zh) * 2021-08-10 2021-11-12 北京恒创星远医药科技有限公司 6-全脱氧-6-全碘代-γ-环糊精晶体及其制备方法和应用
CN115708777A (zh) * 2021-08-19 2023-02-24 北京费森尤斯卡比医药有限公司 包含巯基环糊精衍生物或其可药用盐的包装药品和保存方法
CN119679816A (zh) * 2023-09-15 2025-03-25 杭州奥默医药股份有限公司 一种用于逆转苄异喹啉类肌松药的肌松拮抗药物

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929813A (en) * 1973-12-26 1975-12-30 Interx Research Corp Novel pro-drug derivatives of pyridinium aldoxime type cholinesterase reactivators and process for preparing same
JPS52108027A (en) 1976-03-09 1977-09-10 Rikagaku Kenkyusho Anticarcinogen
US4816462A (en) 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
HU194858B (en) 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
IT1196033B (it) 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8506792D0 (en) 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
GB8613688D0 (en) 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
HU201783B (en) 1987-10-13 1990-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing partially methylized carboxy-acyl-beta-cyclodextrines and salts
US5017566A (en) 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
DE69032370T2 (de) 1989-04-03 1998-10-29 Janssen Pharmaceutica N.V., Beerse Regioselektive substitutionen von cyclodextrinen
US5173481A (en) 1989-04-03 1992-12-22 The United States Of America As Represented By The Department Of Health And Human Services Preparation of specifically substituted cyclodextrins
SU1703657A1 (ru) * 1990-01-23 1992-01-07 Пятигорский фармацевтический институт Соединение включени диэтиламида никотиновой кислоты и @ -циклодекстрина, про вл ющее пролонгированное аналептическое действие
DE69104877T2 (de) * 1990-03-15 1995-03-16 Tanabe Seiyaku Co Polysulfat eines Cyclodextrinderivates und Verfahren zu dessen Herstellung.
US5180716A (en) * 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5180176A (en) * 1991-08-08 1993-01-19 Far Great Plastics Industrial Co., Ltd. Elastic truck for roller skates
JP2556236B2 (ja) 1991-08-29 1996-11-20 田辺製薬株式会社 β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
US5840881A (en) 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
US5767112A (en) 1994-10-21 1998-06-16 Poli Industria Chimica, S.P.A. Muscle relaxant pharmaceutical compositions
AU708107B2 (en) 1994-11-04 1999-07-29 Commonwealth Scientific And Industrial Research Organisation Method for treating animals
GB2307176A (en) * 1995-11-15 1997-05-21 Todd Selwyn Everest Anti-inflammatory clathrating agents for topical use
US5935941A (en) 1997-10-24 1999-08-10 Pitha; Josef Alkylations of cyclodextrins leading to derivatives which have a ridgidly extended cavity
US5834446A (en) * 1996-06-21 1998-11-10 Queen's University At Kingston Nerve process growth modulators
JP4249282B2 (ja) 1998-02-27 2009-04-02 日本食品化工株式会社 新規シクロデキストリン誘導体及びその製造方法
AU776414B2 (en) 1998-05-29 2004-09-09 Neurosciences Research Foundation, Inc. Control of pain with endogenous cannabinoids
US7265099B1 (en) 1999-08-13 2007-09-04 Organon N.V. Use of chemical chelators as reversal agents for drug-induced neuromuscular block
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
US20020111377A1 (en) 2000-12-22 2002-08-15 Albany College Of Pharmacy Transdermal delivery of cannabinoids
CA2437851C (en) 2001-02-14 2011-05-17 Akzo Nobel Nv 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
TW200402417A (en) 2002-06-21 2004-02-16 Akzo Nobel Nv 1-[(Indol-3-yl)carbonyl]piperazine derivatives

Also Published As

Publication number Publication date
PE20010902A1 (es) 2001-09-06
PT1259550E (pt) 2005-05-31
JP4563972B2 (ja) 2010-10-20
CA2390463C (en) 2009-02-03
FR08C0052I2 (fr) 2009-12-18
ATE288450T1 (de) 2005-02-15
ES2237496T3 (es) 2005-08-01
IL149423A0 (en) 2002-11-10
EP1259550B1 (en) 2005-02-02
AU776536B2 (en) 2004-09-16
TWI242015B (en) 2005-10-21
BRPI0015947B8 (pt) 2021-07-06
USRE44733E1 (en) 2014-01-28
CY2008018I1 (el) 2009-11-04
BE2008C047I2 (en:Method) 2019-12-11
AR026605A1 (es) 2003-02-19
WO2001040316A1 (en) 2001-06-07
DE122008000068I1 (de) 2009-04-23
EP1259550A1 (en) 2002-11-27
CO5251450A1 (es) 2003-02-28
SK286282B6 (sk) 2008-06-06
SK7262002A3 (en) 2002-11-06
RU2260013C2 (ru) 2005-09-10
HU227451B1 (en) 2011-06-28
CZ298206B6 (cs) 2007-07-18
MXPA02004940A (es) 2003-05-23
KR20020063900A (ko) 2002-08-05
LU91501I9 (en:Method) 2019-01-02
US6670340B1 (en) 2003-12-30
NO20022522D0 (no) 2002-05-28
NO2010019I1 (no) 2010-11-22
JP2006348301A (ja) 2006-12-28
DE60017947D1 (de) 2005-03-10
NO20022522L (no) 2002-05-28
JP3880041B2 (ja) 2007-02-14
HUP0203755A3 (en) 2003-10-28
NO2010019I2 (no) 2012-08-27
JP2003515623A (ja) 2003-05-07
US20040029833A1 (en) 2004-02-12
CN1402737A (zh) 2003-03-12
CN1188428C (zh) 2005-02-09
DK1259550T3 (da) 2005-04-25
NO328790B1 (no) 2010-05-18
US6949527B2 (en) 2005-09-27
DE122008000068I2 (de) 2011-06-16
AU5438001A (en) 2001-06-12
HK1049489A1 (en) 2003-05-16
KR100716524B1 (ko) 2007-05-10
HUP0203755A2 (hu) 2003-04-28
NL300356I2 (nl) 2009-04-01
CA2390463A1 (en) 2001-06-07
FR08C0052I1 (en:Method) 2009-02-27
DE60017947T2 (de) 2005-06-23
BRPI0015947B1 (pt) 2012-02-07
NZ518752A (en) 2003-03-28
PL203012B1 (pl) 2009-08-31
NL300356I1 (nl) 2008-10-01
BRPI0015947A (pt) 2002-08-20
PL356097A1 (en) 2004-06-14
CZ20021814A3 (cs) 2002-08-14
ZA200203538B (en) 2003-08-04
LU91501I2 (fr) 2009-01-26

Similar Documents

Publication Publication Date Title
CY2008018I2 (el) Παραγωγα 6-μepκαπτο-κυκλοδεξτρινης: παραγοντες αναστροφης του νευρoμυϊκου αποκλεισμου που προκαλειται απο φαρμακευτικες ουσιες
IS5381A (is) 4-fenyl-pyridin afleiður
NO20021077L (no) Amino-triazolopyridin-derivater
DE60009747D1 (de) Admantan-derivate
ATE293104T1 (de) Thiazolylamid-derivate
EE200100613A (et) 13-metüülerütromütsiini derivaadid
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
ATE338021T1 (de) Substituierte 2-dialkylaminoalkylbiphenyl- derivate
PT1237857E (pt) Novos derivados fenalquiloxi-fenilo
NO20021803L (no) Isoksazolkarboksamid-derivater
ATE257148T1 (de) Propargyletherderivate
DK1154988T3 (da) Mevinolinderivater
ATE374747T1 (de) Monofluoralkylderivate
ATE254598T1 (de) 4-hydroxybiphenylhydrazid-derivate
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
ATE293592T1 (de) Resorcinderivate
PT1351959E (pt) Novos derivados de pleuromutilina
DE60003072D1 (de) Thiazolidindion-derivate als antidiabetika
DK1189886T3 (da) Ethansulfonyl-piperidinderivater
TR200002831A3 (tr) Kinolin-4-Il türevleri I
NO20020212D0 (no) 3-amino-2-benzyl-1-fenyl-propanderivater
NO20022867D0 (no) Syklopentenon-derivater
DE60001736D1 (de) 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
ATE269328T1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate